Concepedia

Kenneth E. Rittle

KE

Statistics

Publications

39

Citations

3.9K

H-Index

26

Active since

1976

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Vanderbilt University

Amgen (United States)

Merck Biopharma Co., Ltd. (Japan)

Kenneth E. Rittle is an author at United States Military Academy specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1976–2011

39

Publications

39

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

, , +13

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. Evans, Mark G. Bock, Kenneth E. Rittle et al. · Proceedings of the National Academy of Sciences · 1986 · 328 citations · Full text

, , +16

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Mark G. Bock, Robert M. DiPardo, B. Evans et al. · Journal of Medicinal Chemistry · 1989 · 310 citations · Full text

, , +8

In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α<sub>1A</sub> Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

James C. Barrow, Philippe G. Nantermet, Harold G. Selnick et al. · Journal of Medicinal Chemistry · 2000 · 223 citations · Full text

, , +14

Design, Synthesis, and Evaluation of a Novel 4-Aminomethyl-4-fluoropiperidine as a T-Type Ca<sup>2+</sup>Channel Antagonist

William D. Shipe, James C. Barrow, Zhi-Qiang Yang et al. · Journal of Medicinal Chemistry · 2008 · 133 citations · Full text

, , +16

1–5 of 39